HMOX1 and acute lymphoblastic leukemia: Because such a universal modulatory mechanism seems to be an accurate, objective, easy to perform, and a convenient routine clinical utility, we decided to verify the role of HMOX1 promoter polymorphisms as prognostic marker candidates in BCP-ALL children.